Torrent Pharmaceuticals Limited has reported Consolidated financial results for the period ended June 30, 2022.
Financial Results (Q1 FY2023) - QoQ Comparison
The company has reported total income of Rs. 2377 crores during the period ended June 30, 2022 as compared to Rs. 2187 crores during the period ended March 31, 2022.
The company has posted net profit / (loss) of Rs. 354 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. -118 crores for the period ended March 31, 2022.
The company has reported EPS of Rs. 20.90 for the period ended June 30, 2022 as compared to Rs. -6.98 for the period ended March 31, 2022.
Total Income | ₹ 2377 crs | ₹2187 crs | 8.69% |
Net Profit | ₹354 crs | ₹-118 crs | 400.00% |
EPS | ₹20.90 | ₹-6.98 | 399.43% |
Financial Results (Q1 FY2023) - YoY Comparison The company has reported total income of Rs. 2377 crores during the period ended June 30, 2022 as compared to Rs.2174 crores during the period ended June 30, 2021.
The company has posted net profit / (loss) of Rs.354 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.330 crores for the period ended June 30, 2021.
The company has reported EPS of Rs.20.90 for the period ended June 30, 2022 as compared to Rs.19.53 for the period ended June 30, 2021.
Total Income | ₹ 2377 crs | ₹2174 crs | 9.34% |
Net Profit | ₹354 crs | ₹330 crs | 7.27% |
EPS | ₹20.90 | ₹19.53 | 7.01% |
Shares of Torrent Pharmaceuticals Limited was last trading in BSE at Rs. 1528.80 as compared to the previous close of Rs. 1502.45. The total number of shares traded during the day was 5186 in over 810 trades.
The stock hit an intraday high of Rs. 1534.40 and intraday low of 1501.00. The net turnover during the day was Rs. 7867947.00.
Source : Equity Bulls
Keywords
TorrentPharmaceuticals
Q1FY23
ResultUpdate